Fusion Protein Enzyme for Biocatalytic Reduction of Cystine to Cysteine

Sat, 18 Apr 2026 01:22:55 +0000
Intellectual Property

USPTO granted patent US12600995B2 to Wacker Chemie AG for a fusion protein enzyme combining thioredoxin and thioredoxin reductase activities from E. coli to catalyze the reduction of cystine to cysteine. The patent contains 7 claims and was assigned CPC classifications related to biochemistry and peptide chemistry.